| | | |
DEB(+BMS)
|
DES
| | | |
DEB
|
DES
|
|
Adriaenssens 2014 [30] SEDUCE
|
BMS-ISR
|
50
|
PEB(SeQuent Please)
|
EES(XIENCE V/Prime)
|
NA
|
NA
|
9 (angio), 12 (clinical)
|
25/25
|
25/25
|
|
Alfonso 2015 [31] RIBS IV
|
DES-ISR
|
309
|
PEB(SeQuent Please)
|
EES(XIENCE Prime)
|
3 after DEB, 12 after DES
|
NA
|
6–9 angio), 12–36 (clinical)
|
154/154
|
155/155
|
|
Alfonso 2014 [32] RIBS V
|
BMS-ISR
|
189
|
PEB(SeQuent Please)
|
EES(XIENCE Prime)
|
3 after DEB, 12 after DES
|
NA
|
6–9 (angio), 12 (clinical)
|
95/95
|
94/94
|
|
Ali 2011 [39] PEPCAD IV
|
coronary stenoses in patients with DM
|
84
|
DEB(SeQuent Please) + cobalt-chromium stent(Coroflex Blue)
|
DES (Taxus Liberté)
|
3 after DEB, 6 after DES
|
NA
|
9
|
14/45
|
38/39
|
|
Belkacemi 2012 [23] DEB-AMI
|
AMI
|
99
|
DIOR 2 DEB + cobalt-chromium stent
|
DES (Taxus Liberté)
|
12
|
MI, TVR, death
|
6
|
30/50
|
49/49
|
|
Byrne 2013 [33] ISAR-DESIRE 3
|
DES-ISR
|
268
|
DEB(SeQuent Please)
|
DES (Taxus Liberté)
|
6
|
Death, MI, TLR
|
6–8 (angio), 12–36 (clinical)
|
139/172
|
145/168
|
|
Chae 2017 [24]
|
De novo lesions
|
180
|
DEB(Sequent® Please) + BMS(Coroflex® Blue)
|
ZES(Resolute Integrity)
|
9
|
TLR, MI, cardiac death
|
12
|
74/74
|
72/72
|
|
Clever 2014 [25]
|
De novo lesions
|
52
|
DEB(Braun) + BMS(Coroflex Blue)
|
SES(Cypher)
|
9
|
TLR, MI, ST, death
|
9
|
16/27
|
16/25
|
|
Cortese 2010 [37] PICCOLETO
|
small coronary vessels
|
60
|
DIOR 1 DEB
|
DES (Taxus Liberté)
|
1 after DEB, 3 after BMS, 12 after DES
|
Death, STEMI, TLR
|
6 (angio), 9(clinical)
|
7/28
|
25/29
|
|
Herdeg 2009 [26]
|
De novo stenoses
|
136
|
BMS (Multi-Link Zeta, Guidant)followed by catheter-based local delivery of fluid paclitaxel
|
DES (Taxus Liberté)
|
6
|
TLR, MI, subacute closure, or death
|
6
|
NA
|
NA
|
|
Latib 2012 [38] BELLO
|
Small Coronary Vessels
|
182
|
IN.PACT Falcon DEB
|
DES (Taxus Liberté)
|
1 after DEB, 12 after DES
|
Death, MI,TVR
|
6 (angio), 6–36 (clinical)
|
91/94
|
81/98
|
|
Liistro 2013 [27]
|
de novo coronary stenosis
|
125
|
Elutax PEB + cobalt-chromium
|
EES(XIENCE Prime)
|
3 after DEB, 12 after DES
|
MI, death, TLR
|
9
|
NA
|
NA
|
|
Minguez 2014 [41] BABILON
|
de novo bifurcated coronary lesions
|
108
|
DEB(SeQuent Please) + cobalt-Chromium stent(Coroflex Blue)
|
EES(XIENCE Prime)
|
3 after DEB, 12 after DES
|
Death, MI, TLR
|
9(angio), 24 (clinical)
|
43/43
|
43/43
|
|
Pleva 2016 [34]
|
BMS-ISR
|
136
|
PEB(SeQuent Please)
|
EES(Promus Element)
|
3 after DEB, 6–12 after DES
|
MI, TVR, Cardiac death
|
12
|
69/69
|
68/68
|
|
Poerner 2014 [28]
|
coronary artery disease
|
90
|
DEB(SeQuent Please) + cobalt-chromium stent(Coroflex Blue)
|
EES(XIENCE Prime)
|
NA
|
NA
|
6
|
NA
|
NA
|
|
Stella 2012 [40]
|
coronary bifurcation lesions
|
80
|
Dior I DEB + Liberte BMS
|
DES (Taxus Liberté)
|
3 after DEB, 12 after DES
|
MI, TVR, Death
|
12
|
33/33
|
37/37
|
|
Unverdorben 2009 [35] PEPCAD II
|
ISR
|
131
|
PEB(SeQuent Please)
|
DES (Taxus Liberté)
|
3 after DEB, 6 after DES
|
MI, TLR, Cardiac Death, Stent thrombosis
|
6 (angio), 12–36 (clinical)
|
66/66
|
65/65
|
|
Xu 2014 [36] PEPCAD China ISR
|
DES-ISR
|
215
|
PEB(SeQuent Please)
|
DES (Taxus Liberté)
|
12
|
MI, TLR, Cardiac death
|
9 (angio), 12 (clinical)
|
112/113
|
107/108
|
|
Zurakowski 2015 [29]
|
de novo coronary lesions
|
202
|
DEB(Sequent Please) + BMS
|
DES(Coroflex Please)
|
12
|
MI, TVR, Cardiac death
|
9
|
NA
|
NA
|
